Free Trial

InMed Pharmaceuticals (INM) Short Interest Ratio & Short Volume

InMed Pharmaceuticals logo
$4.70 +0.47 (+11.11%)
(As of 01:51 PM ET)

InMed Pharmaceuticals Short Interest Data

InMed Pharmaceuticals (INM) has a short interest of 115,500 shares. This marks a 188.75% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 120,770 shares to cover all short positions.

Current Short Interest
115,500 shares
Previous Short Interest
40,000 shares
Change Vs. Previous Month
+188.75%
Dollar Volume Sold Short
$30,711.45
Short Interest Ratio
0.0 Days to Cover
Last Record Date
October 31, 2024
Outstanding Shares
720,000 shares
Percentage of Shares Shorted
16.04%
Today's Trading Volume
34,950 shares
Average Trading Volume
120,770 shares
Today's Volume Vs. Average
29%
Short Selling InMed Pharmaceuticals?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for InMed Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

INM Short Interest Over Time

INM Days to Cover Over Time

INM Percentage of Float Shorted Over Time

InMed Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/31/2024115,500 shares $30,711.45 +188.8%N/A0 $0.27
10/15/202440,000 shares $8,760.00 -57.1%N/A0 $0.22
9/30/202493,200 shares $22,088.40 -82.6%N/A0 $0.24
9/15/2024534,900 shares $139,822.86 +55.3%N/A0.1 $0.26
8/31/2024344,500 shares $122,263.05 +818.7%N/A0 $0.35
8/15/202437,500 shares $5,400.00 -85.2%N/A0 $0.14
7/31/2024253,200 shares $44,512.56 +85.2%N/A0.2 $0.18
7/15/2024136,700 shares $36,457.89 +61.4%N/A0.1 $0.27
6/30/202484,700 shares $22,487.85 -43.5%N/A0.1 $0.27
6/15/2024150,000 shares $34,005.00 +252.9%N/A0.2 $0.23
5/31/202442,500 shares $12,537.50 -44.6%N/A0.1 $0.30
5/15/202476,700 shares $21,015.34 -78.6%N/A0.2 $0.27
4/30/2024359,000 shares $96,571.00 +213.5%N/A0.9 $0.27
4/15/2024114,500 shares $36,491.15 +1,011.7%N/A0.3 $0.32
3/31/202410,300 shares $3,749.20 -81.9%N/A0 $0.36
3/15/202457,000 shares $20,520.00 -13.9%N/A0.3 $0.36
2/29/202466,200 shares $27,473.00 -52.1%N/A0.3 $0.42
2/15/2024138,300 shares $47,990.10 +244.9%N/A0.7 $0.35
1/31/202440,100 shares $14,431.99 -43.4%N/A0.2 $0.36
1/15/202470,800 shares $27,081.00 -47.2%N/A0 $0.38
12/31/2023134,000 shares $55,744.00 +1,213.7%N/A0.1 $0.42
12/15/202310,200 shares $3,672.00 -65.9%N/A0 $0.36
11/30/202329,900 shares $13,156.00 +510.2%N/A0 $0.44
11/15/20234,900 shares $1,989.40 -74.1%N/A0 $0.41
10/31/202318,900 shares $9,143.82 +339.5%N/A0 $0.48
10/15/20234,300 shares $2,743.40 +377.8%N/A0 $0.64
9/30/2023900 shares $629.91 -90.1%N/A0 $0.70
9/15/20239,100 shares $7,683.13 -65.4%N/A0.2 $0.84
8/31/202326,300 shares $21,592.30 +64.4%N/A0.5 $0.82
8/15/202316,000 shares $14,961.60 -61.5%N/A0.2 $0.94
7/31/202341,500 shares $46,480.00 +112.8%N/A0.5 $1.12
7/15/202319,500 shares $18,721.95 +2.6%N/A0.2 $0.96
6/30/202319,000 shares $17,480.00 -63.2%N/A0.2 $0.92
6/15/202351,600 shares $65,532.00 +4.7%N/A0.4 $1.27
5/31/202349,300 shares $66,062.00 -24.0%N/A0.1 $1.34
5/15/202364,900 shares $75,284.00 -30.8%N/A0.1 $1.16
4/30/202393,800 shares $112,560.00 -25.7%N/A0.2 $1.20
4/15/2023126,300 shares $157,875.00 +3.8%N/A0.2 $1.25
3/31/2023121,700 shares $131,436.00 -27.7%N/A0.2 $1.08
3/15/2023168,400 shares $178,504.00 +194.9%N/A0.2 $1.06
Breaking News: Tesla headed to $500… (Ad)

That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla.

So to claim your free digital copy today, simply follow this link and enter your email address. 
2/28/202357,100 shares $75,943.00 -15.8%N/A0.1 $1.33
2/15/202367,800 shares $113,226.00 -7.6%N/A0.1 $1.67
1/31/202373,400 shares $135,056.00 -75.4%N/A0.1 $1.84
1/15/2023297,800 shares $562,842.00 +443.4%3.8%0.3 $1.89
12/30/202254,800 shares $110,696.00 +13.0%0.7%0.1 $2.02
12/15/202248,500 shares $90,210.00 +62.8%0.6%0.1 $1.86
11/30/202229,800 shares $78,970.00 +223.9%0.4%0 $2.65
11/15/20229,200 shares $25,576.00 -32.9%0.1%0 $2.78
10/31/202213,700 shares $41,785.00 +121.0%0.2%0 $3.05
10/15/20226,200 shares $32,922.00 -83.9%0.1%0 $5.31
9/30/202238,600 shares $254,516.82 -57.3%0.5%0 $6.59
9/15/202290,300 shares $867,783.00 +12,800.0%1.2%0.1 $9.61
8/31/2022700 shares $4,165.00 -89.4%N/A0 $5.95
8/15/20226,600 shares $2,571.36 -62.5%0.1%0 $0.39
7/31/202217,600 shares $6,864.00 -18.9%0.2%0.1 $0.39
7/15/202221,700 shares $8,029.00 +6.4%0.3%0.1 $0.37
6/30/202220,400 shares $9,596.16 -80.1%0.3%0.1 $0.47
6/15/2022102,300 shares $53,400.60 +47.6%1.3%0.5 $0.52
5/31/202269,300 shares $53,361.00 -29.4%0.9%0.3 $0.77
5/15/202298,100 shares $81,423.00 -34.3%1.3%0.5 $0.83
4/30/2022149,300 shares $135,863.00 -8.7%1.9%0.7 $0.91
4/15/2022163,600 shares $142,806.44 +34.1%2.1%0.8 $0.87
3/31/2022122,000 shares $115,009.40 +114.4%1.6%0.9 $0.94
3/15/202256,900 shares $41,024.90 -35.3%0.7%0.6 $0.72
2/28/202287,900 shares $82,819.38 +2.6%1.1%0.8 $0.94
2/15/202285,700 shares $99,412.00 -2.7%1.1%0.3 $1.16
1/31/202288,100 shares $106,601.00 -15.7%1.1%0 $1.21
1/15/2022104,500 shares $129,580.00 +74.5%1.3%0 $1.24
12/31/202159,900 shares $78,469.00 -8.4%0.8%0 $1.31
12/15/202165,400 shares $96,792.00 -56.5%0.8%0 $1.48
11/30/2021150,400 shares $285,760.00 +69.9%1.9%0.1 $1.90
11/15/202188,500 shares $118,590.00 -19.7%1.1%0 $1.34
10/29/2021110,200 shares $168,055.00 +69.3%1.4%0.2 $1.53
10/15/202165,100 shares $91,140.00 -2.5%0.8%0.1 $1.40
9/30/202166,800 shares $116,900.00 +189.2%0.8%0.3 $1.75
9/15/202123,100 shares $47,553.66 +216.4%0.3%0.2 $2.06
8/31/20217,300 shares $16,133.00 -92.4%0.1%0.1 $2.21
8/13/202196,600 shares $231,840.00 -47.8%1.2%1.4 $2.40
7/30/2021185,100 shares $516,429.00 +98.2%2.3%2.6 $2.79
7/15/202193,400 shares $249,378.00 +396.8%1.2%1.3 $2.67
6/30/202118,800 shares $59,784.00 +37.2%0.2%0.2 $3.18
6/15/202113,700 shares $39,045.00 -2.8%0.2%0.2 $2.85
5/28/202114,100 shares $41,595.00 +30.6%0.2%0.2 $2.95
5/14/202110,800 shares $30,348.00 -90.7%0.1%0.1 $2.81
4/30/2021115,800 shares $431,934.00 -14.7%1.5%0.7 $3.73
4/15/2021135,800 shares $435,918.00 -64.8%1.7%0.7 $3.21
3/31/2021385,200 shares $1.21 million -6.6%4.8%1.8 $3.13
3/15/2021412,600 shares $1.96 million +0.3%5.2%1.8 $4.75
2/26/2021411,400 shares $1.80 million +7.3%5.9%1.7 $4.37
2/12/2021383,500 shares $2.05 million +177.1%5.5%1.6 $5.35
Breaking News: Tesla headed to $500… (Ad)

That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla.

So to claim your free digital copy today, simply follow this link and enter your email address. 
1/29/2021138,400 shares $546,693.84 +63.2%2.0%0.6 $3.95
1/15/202184,800 shares $367,184.00 No Change1.2%0.7 $4.33

INM Short Interest - Frequently Asked Questions

What is InMed Pharmaceuticals' current short interest?

Short interest is the volume of InMed Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of October 31st, investors have sold 115,500 shares of INM short. Learn More on InMed Pharmaceuticals' current short interest.

Is InMed Pharmaceuticals' short interest increasing or decreasing?

InMed Pharmaceuticals saw a increase in short interest in October. As of October 31st, there was short interest totaling 115,500 shares, an increase of 188.8% from the previous total of 40,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does InMed Pharmaceuticals' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to InMed Pharmaceuticals: Sol-Gel Technologies Ltd. (0.39%), NLS Pharmaceutics Ltd. (1.27%), ANEW Medical, Inc. (1.67%), Sensei Biotherapeutics, Inc. (1.18%), Aspira Women's Health Inc. (4.86%), Talphera, Inc. (0.60%), Turnstone Biologics Corp. (2.69%), Conduit Pharmaceuticals Inc. (3.72%), Indaptus Therapeutics, Inc. (1.85%), Kiora Pharmaceuticals, Inc. (1.76%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

What does it mean to sell short InMed Pharmaceuticals stock?

Short selling INM is an investing strategy that aims to generate trading profit from InMed Pharmaceuticals as its price is falling. INM shares are trading up $0.47 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against InMed Pharmaceuticals?

A short squeeze for InMed Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of INM, which in turn drives the price of the stock up even further.

How often is InMed Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including INM, twice per month. The most recent reporting period available is October, 31 2024.




This page (NASDAQ:INM) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners